Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 46960-46961 [2018-20110]
Download as PDF
<![CDATA[
46960
Federal Register / Vol. 83, No. 180 / Monday, September 17, 2018 / Notices
Blood Safety.’’ The purpose of the
public workshop is to foster the
development and implementation of
pathogen reduction technologies for
blood components intended for
transfusion. The workshop will include
presentations and panel discussions by
experts from academic institutions,
industry, and government agencies.
The public workshop will be
held on November 29, 2018, from 8 a.m.
to 5 p.m., and on November 30, 2018,
from 9 a.m. to 1 p.m. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
DATES:
The public workshop will
be held at the FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503, sections B and C), Silver Spring,
MD 20993. Entrance for the public
workshop participants (non-FDA
employees) is through Building 1, where
routine security check procedures will
be performed. For parking and security
information, please refer to https://
www.fda.gov/AboutFDA/Workingat
FDA/BuildingsandFacilities/WhiteOak
CampusInformation/ucm241740.htm.
ADDRESSES:
Loni
Warren Henderson or Sherri Revell,
Center for Biologics Evaluation and
Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 240–
402–8010, email: CBERPublicEvents@
fda.hhs.gov (subject line: Pathogen
Reduction Technology and Blood
Safety).
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
daltland on DSKBBV9HB2PROD with NOTICES
I. Background
Pathogen reduction technology has
the potential to improve blood safety by
reducing or eliminating infectious
organisms, including bacteria, viruses,
and parasites, from blood components
intended for transfusion. FDA granted
approvals for use of a pathogen
reduction technology platform in
manufacturing plasma and apheresis
platelets for transfusion. Ideally,
pathogen reduction technology should
also be available for whole blood and
red blood cells. Implementation of safe
and effective pathogen reduction
technology may also permit alternative
donor screening or donation testing
strategies in the future. The purpose of
the public workshop is to foster the
development and implementation of
pathogen reduction technologies for all
blood components intended for
transfusion.
VerDate Sep<11>2014
17:47 Sep 14, 2018
Jkt 244001
II. Topics for Discussion at the Public
Workshop
The first day of the workshop will
include presentations and panel
discussions on the following topics: (1)
Transfusion-transmitted infectious
agents and their impact on blood safety;
(2) status of pathogen reduction
technology for blood components
intended for transfusion, including
challenges to implementation in the
United States; and (3) the development
of pathogen reduction technology for
whole blood and red blood cells.
The second day of the workshop will
include presentations and panel
discussions on the following topics: (1)
Emerging pathogen reduction
technologies and alternative approaches
to controlling risk; (2) potential funding
opportunities for research; and (3) a
summary of all workshop sessions,
panel discussions, and future directions.
III. Participating in the Public
Workshop
Registration: To register for the public
workshop, please visit the following
website: https://www.eventbrite.com/e/
pathogen-reduction-technologies-forblood-safety-public-workshop-tickets4464956605. Please provide complete
contact information for each attendee,
including name, title, affiliation,
address, email, and telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public workshop must
register by November 8, 2018, midnight
Eastern Time. Early registration is
recommended because seating is
limited; therefore, FDA may limit the
number of participants from each
organization. If time and space permit,
onsite registration on the day of the
public workshop will be provided,
beginning at 7 a.m.
If you need special accommodations,
due to a disability, please contact Loni
Warren Henderson or Sherri Revell no
later than November 19, 2018 (see FOR
FURTHER INFORMATION CONTACT). Request
for sign language interpretation or
Computer Aided Realtime Translation
(CART)/captioning should be made 2
weeks in advance of the event, no later
than November 15, 2018. A request for
either interpreting or captioning should
be sent directly to the FDA Interpreting
Services Staff email account:
interpreting.services@oc.fda.gov.
Streaming Webcast of the Public
Workshop: This public workshop will
also be webcast. Individuals who wish
to view the webcast should register for
the workshop at https://
www.eventbrite.com/e/pathogen-
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
reduction-technologies-for-blood-safetypublic-workshop-tickets-4464956605. A
link to the live webcast will be provided
upon registration.
If you have never attended a Connect
Pro event before, test your connection at
https://collaboration.fda.gov/common/
help/en/support/meeting_test.htm. To
get a quick overview of the Connect Pro
program, visit https://www.adobe.com/
go/connectpro_overview. FDA has
verified the website addresses in this
document as of the date this document
publishes in the Federal Register, but
websites are subject to change over time.
Transcripts: Please be advised that as
soon as a transcript of the public
workshop is available, it will be
accessible at https://www.regulations.
gov. It may be viewed at the Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852. A
link to the transcript will also be
available on the internet at https://
www.fda.gov/BiologicsBloodVaccines/
NewsEvents/WorkshopsMeetings
Conferences/default.htm.
Dated: September 11, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–20090 Filed 9–14–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council on Alzheimer’s
Research, Care, and Services provides
advice on how to prevent or reduce the
burden of Alzheimer’s disease and
related dementias on people with the
disease and their caregivers. During the
October meeting, the Long-Term
Services and Supports Subcommittee
will be taking charge of the theme. The
topics covered will include: (1) The
experience of people with dementia
who have special needs due to issues
like diversity, geography, and
concurrent disorders; (2) How clinical
care can be better integrated with
community-based supports and
services; and (3) Evidence-based
behavioral approaches that mitigate the
impact of behavioral symptoms of
dementia. The meeting will also include
SUMMARY:
E:\FR\FM\17SEN1.SGM
17SEN1
Federal Register / Vol. 83, No. 180 / Monday, September 17, 2018 / Notices
updates on work from the previous
meetings and federal workgroup
updates.
The meeting will be held on
October 19, 2018 from 9 a.m. to 5 p.m.
EDT.
ADDRESSES: The meeting will be held in
Room 800 in the Hubert H. Humphrey
Building, 200 Independence Avenue
SW, Washington, DC 20201.
Comments: Time is allocated in the
afternoon on the agenda to hear public
comments. The time for oral comments
will be limited to two (2) minutes per
individual. In lieu of oral comments,
formal written comments may be
submitted for the record to Rohini
Khillan, OASPE, 200 Independence
Avenue SW, Room 424E, Washington,
DC 20201. Comments may also be sent
to napa@hhs.gov. Those submitting
written comments should identify
themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Rohini Khillan (202) 690–5932,
rohini.khillan@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘October 19
Meeting Attendance’’ in the Subject line
by Wednesday, October 10, so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the Department of Health and
Human Services. Any interested
member of the public who is a non-U.S.
citizen should include this information
at the time of registration to ensure that
the appropriate security procedure to
gain entry to the building is carried out.
Although the meeting is open to the
public, procedures governing security
and the entrance to Federal buildings
may change without notice. If you wish
to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: During
the October meeting, the Long-Term
Services and Supports Subcommittee
will be taking charge of the theme. The
topics covered will include: (1) The
experience of people with dementia
who have special needs due to issues
like diversity, geography, and
concurrent disorders; (2) How clinical
care can be better integrated with
community-based supports and
services; and (3) Evidence-based
behavioral approaches that mitigate the
impact of behavioral symptoms of
dementia. The meeting will also include
updates on work from the previous
daltland on DSKBBV9HB2PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:47 Sep 14, 2018
Jkt 244001
meetings and federal workgroup
updates.
Procedure and Agenda: This meeting
is open to the public. Please allow 30
minutes to go through security and walk
to the meeting room. The meeting will
also be webcast at www.hhs.gov/live.
Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Dated: September 10, 2018.
Brenda Destro,
Deputy Assistant Secretary for Planning and
Evaluation, Office of Human Services Policy.
[FR Doc. 2018–20110 Filed 9–14–18; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Next
Generation of Basic Alzheimer’s Disease
Researchers.
Date: October 17–18, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ramesh Vemuri, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, 7201 Wisconsin
Avenue, Suite 2C–212, Bethesda, MD 20892,
301–402–7700, rv23r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
46961
Dated: September 11, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–20111 Filed 9–14–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative Physiology of Obesity and
Diabetes Study Section.
Date: October 9–10, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 E Wacker Drive, Chicago, IL
60601.
Contact Person: Raul Rojas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
Bethesda, MD 20892, (301) 451–6319, rojasr@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Behavioral
Genetics and Epidemiology.
Date: October 10, 2018.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW, Washington, DC 20036.
Contact Person: Karen Nieves Lugo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892,
karen.nieveslugo@nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Radiation Therapeutics and Biology
Study Section.
Date: October 11–12, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 83, Number 180 (Monday, September 17, 2018)]
[Notices]
[Pages 46960-46961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20110]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Council on Alzheimer's Research, Care, and Services;
Meeting
AGENCY: Assistant Secretary for Planning and Evaluation, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the public meeting of the Advisory
Council on Alzheimer's Research, Care, and Services (Advisory Council).
The Advisory Council on Alzheimer's Research, Care, and Services
provides advice on how to prevent or reduce the burden of Alzheimer's
disease and related dementias on people with the disease and their
caregivers. During the October meeting, the Long-Term Services and
Supports Subcommittee will be taking charge of the theme. The topics
covered will include: (1) The experience of people with dementia who
have special needs due to issues like diversity, geography, and
concurrent disorders; (2) How clinical care can be better integrated
with community-based supports and services; and (3) Evidence-based
behavioral approaches that mitigate the impact of behavioral symptoms
of dementia. The meeting will also include
[[Page 46961]]
updates on work from the previous meetings and federal workgroup
updates.
DATES: The meeting will be held on October 19, 2018 from 9 a.m. to 5
p.m. EDT.
ADDRESSES: The meeting will be held in Room 800 in the Hubert H.
Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201.
Comments: Time is allocated in the afternoon on the agenda to hear
public comments. The time for oral comments will be limited to two (2)
minutes per individual. In lieu of oral comments, formal written
comments may be submitted for the record to Rohini Khillan, OASPE, 200
Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may
also be sent to [email protected]. Those submitting written comments should
identify themselves and any relevant organizational affiliations.
FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932,
[email protected]. Note: Seating may be limited. Those wishing to
attend the meeting must send an email to [email protected] and put ``October
19 Meeting Attendance'' in the Subject line by Wednesday, October 10,
so that their names may be put on a list of expected attendees and
forwarded to the security officers at the Department of Health and
Human Services. Any interested member of the public who is a non-U.S.
citizen should include this information at the time of registration to
ensure that the appropriate security procedure to gain entry to the
building is carried out. Although the meeting is open to the public,
procedures governing security and the entrance to Federal buildings may
change without notice. If you wish to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: During the October meeting, the Long-
Term Services and Supports Subcommittee will be taking charge of the
theme. The topics covered will include: (1) The experience of people
with dementia who have special needs due to issues like diversity,
geography, and concurrent disorders; (2) How clinical care can be
better integrated with community-based supports and services; and (3)
Evidence-based behavioral approaches that mitigate the impact of
behavioral symptoms of dementia. The meeting will also include updates
on work from the previous meetings and federal workgroup updates.
Procedure and Agenda: This meeting is open to the public. Please
allow 30 minutes to go through security and walk to the meeting room.
The meeting will also be webcast at www.hhs.gov/live.
Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National
Alzheimer's Project Act. The panel is governed by provisions of
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of advisory committees.
Dated: September 10, 2018.
Brenda Destro,
Deputy Assistant Secretary for Planning and Evaluation, Office of Human
Services Policy.
[FR Doc. 2018-20110 Filed 9-14-18; 8:45 am]
BILLING CODE 4150-05-P
